XBI icon

SPDR S&P Biotech ETF

700 hedge funds and large institutions have $7.06B invested in SPDR S&P Biotech ETF in 2022 Q1 according to their latest regulatory filings, with 123 funds opening new positions, 242 increasing their positions, 186 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 2020 (0)

7% less capital invested

Capital invested by funds: $7.55B → $7.06B (-$497M)

7.65% less ownership

Funds ownership: 105.41%97.76% (-7.7%)

Holders
700
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
20
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.67B
Puts
$2.59B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
201
$2.2M
202
$2.17M
203
$2.17M
204
$2.15M
205
$2.12M
206
$2.09M
207
$2.08M
208
$2.04M
209
$1.99M
210
$1.98M
211
$1.95M
212
$1.94M
213
$1.93M
214
$1.93M
215
$1.91M
216
$1.9M
217
$1.88M
218
$1.83M
219
$1.83M
220
$1.81M
221
$1.78M
222
$1.77M
223
$1.72M
224
$1.72M
225
$1.71M